Skin Health Study Seeks Participants Struggling With Severe Itching

Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: ACRC Trials
Location: 5425 W. Spring Creek Parkway, Plano, TX, 75024
Lead Researcher: Seemal Desai, M.D., FAAD
IRB Committee: This study has been reviewed and approved by the IntegReview Institutional Review Board


Atopic dermatitis (also known as Eczema) is an inflammatory skin condition that affects nearly 20% of children and about 2-10% of adults. Pruritus is a common condition linked with atopic dermatitis. Pruritus is an urge to itch or an unpleasant sensation that produces the urge to itch and scratch. Physicians consider the management of this skin condition a challenge. Researchers are continually understanding and developing effective treatment options for pruritus associated with atopic dermatitis (eczema).

This study seeks to evaluate the effectiveness of a potential treatment for severe itching of the skin (pruritus) among adults with a history of atopic dermatitis (eczema). The potential study product will be administered on the skin via a topical spray.

Interested participants must be 18 to 65 years old who have severe itching of the skin (pruritus) with a history of atopic dermatitis (eczema). Participants must be willing to comply with the necessary study requirements. Compensation will be available for eligible participants.

Why Participate? 

  • You may receive a potential topical spray for your skin condition at no cost.
  • You may experience improvements to your signs and symptoms.
  • You will be compensated up to $375 for participating in this study.
  • You will receive all dermatology visits and research-related supplies at no cost.
  • You will be helping to advance skin health research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Adults aged 18 to 65 years old who have severe itching of the skin (pruritus)
  • Participants must have atopic dermatitis (eczema).
  • Participants must be able to attend 5 study visits at the research site for over approximately 11 weeks as well as be willing to comply with the following requirements:
    • Participants must be willing to complete daily diary entries.
    • Participants must be willing to answer 2 scheduled phone calls with the study team.
    • Participants must apply the study product on their skin twice a day as instructed by the study team.

About The Research Center:

ACRC Trials
ACRC Trials has conducted clinical studies involving volunteers for nationally and internationally recognized pharmaceutical and biotechnology companies. As a leader in research,  ACRC Trials’ mission is to provide exceptional services and to set the standard of excellence in coordinating clinical trials so patients can enjoy the benefits of approved treatments. ACRC Trials aims to advance medical treatments, establish ourselves and our team of top-notch physicians as leaders in clinical research, and offer our research team a great place to work.

Please note:

Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:

  • The research site does not treat COVID-19 patients and/or suspected COVID-19 patients.
  • The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
  • Hand sanitisers are available at the research site.
  • The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
  • Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
  • Interested participants will not be left waiting for a long period of time and will be quickly attended to. 
  • Parking is available at the research site.
  • The study team encourages the use of personal vehicles, taxi or rideshare services rather than public transit. All travel expenses will be reimbursed.
  • The research site/institution is taking all precautionary measures to ensure the safety of the study participants. 

What Next?

  1. Click the link below to enter your contact details and take the study questionnaire.
  2. If eligible, a member of the research team will contact you to discuss the study and answer any questions you may have.
Click Here to Check Your Eligibility for This Study